Multiresistance of clinically relevant gram-positive cocci;Multiresistenz bei klinisch relevanten grampositiven Kokken

Intensivmedizin und Notfallmedizin

Volumn 34, Issue 7, 1997, Pages 655-663

  Von Eiff, C ^a   Becker, K ^a   Peters, G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Antibiotic therapy; Gram positive cocci; Multiresistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; LINCOSAMIDE DERIVATIVE; MACROLIDE; METICILLIN; MEZLOCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLINASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030663254     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050089     Document Type: Review

References (91)

1. Aldridge KE, Gelfand MS, Schiro DD, Barg NL (1992) The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents. Diagn Microbiol Infect Dis 15: 601-608
2. Aldridge KE, Schiro DD, Varner LM (1992) In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods. Antimicrob Agents Chemother 36: 854-855
3. Anonymous (1993) Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR 42: 597-599
4. Appelbaum PC, Bhamjee A, Scragg JN, Hallett AF, Bowen AJ, Cooper RC (1977) Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 2: 995-997
5. Archer GL, Armstrong BC (1983) Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylaxis. J Infect Dis 147: 642-649
6. Archer GL, Climo MW (1994) Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 38: 2231-2237
7. Archer GL, Karchmer AW, Vishniavsky N, Johnston JL (1984) Plasmid-pattern analysis for the differentiation of infecting from noninfecting Staphylococcus epidermidis. J Infect Dis 149: 913-920
8. Archer GL, Scott J (1991) Conjugative transfer genes in staphylococcal isolates from the United States. Antimicrob Agents Chemother 35: 2500-2504
9. Arthur M, Courvalin P (1993) Genetics and mechanisms of glycopeptide resistance in enterococci. Antikmicrob Agents Chemother 37: 1563-1571
10. Bannerman TL, Wadiak DL, Kloos WE (1991) Susceptibility of Staphylococcus species and subspecies to teicoplanin. Antimicrob Agents Chemother 35: 1919-1922
11. Beck WD, Berger-Bächi B, Kayser FH (1986) Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of mec-specific DNA. J Bacteriol 165: 373-378
12. Berger-Bächi B (1996) Update on methicillin resistance mechanisms in staphylococci. Chemotherapy 42 (Suppl 2): 19-26
13. Bradley JS, Connor JD (1991) Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J 10: 871-973
14. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR (1994) Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271: 1831-1835
15. Burdeska A, Then RL (1990) Clinical importance of trimethoprim resistance in staphylococci isolated in Europe. J Med Microbiol 31: 1-19
16. Coffey TJ, Dowson CG, Daniels M, Zhou J, Martin C, Spratt BG, Musser JM (1991) Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol 5: 2255-2260
17. Cookson BD (1993) MRSA: major problem or minor threat? [editorial]. J Med Microbiol 38: 309-310
18. Cormican MG, Jones RN (1996) Emerging resistance to antimicrobial agents in gram-positive bacteria. Drugs Suppl:6-12
19. de Lencastre H, de Jonge BL, Matthews PR, Tomasz A (1994) Molecular aspects of methicillin resistance in Staphylococcus aureus. J Antimicrob Chemother 33: 7-24
20. Dowson CG, Coffey TJ, Spratt BG (1994) Origin and molecular epidemiology of penicillin-binding protein-mediated resistance to β-lactam antibiotics. Trends in Microbiol 2: 361-366
21. Dryden MS, Talsania H, McCann M, Cookson BD, Phillips I (1992) The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients. Epidemiol Infect 109: 97-112
22. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP (1995) Vancomycin-resistant Enterococcus faecium bacteremia: risk factors, for. Clin Infect Dis 20: 5126-1133
23. Eliopoulos GM, Wennersten CB, Gold HS, Moellering RC, Jr (1996) In vitro activities in new oxazolidinone antimicrobial agents against enterococci. Antimicrob Agents Chemother 40: 1745-1747
24. Fenoll A, Martin Bourgon C, Munoz R, Vicioso D, Casal J (1991) Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain. 1979-1989. Rev Infect Dis 13: 56-60
25. Figueiredo AM, Connor JD, Severin A, Vaz Pato MV, Tomasz A (1992) A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob Agents Chemother 36: 886-889
26. Finch RG (1996) Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use. Drugs 51 Suppl 1: 31-37
27. Forbes BA, Schaberg DR (1983) Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: evidence for conjugative exchange of resistance. J Bacteriol 153: 627-634
28. French G, Abdulla Y, Heathcock R, Poston S, Cameron J (1992) Vancomycin resistance in south London [letter]. Lancet 339: 818-819
29. Friedland IR. McCracken GH, Jr (1994) Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 331: 377-382
30. Geslin P, Buu Hoi A, Fremaux A, Acar JF (1992) Antimicrobial resistance in Streptococcus pneumonias: an epidemiological survey in France, 1970-1990. Clin Infect Dis 15: 95-98
31. Goldstein FW, Coutrot A, Sieffer A, Acar JF (1990) Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother 34: 899-900
32. Goldstein FW, Garau J (1994) Resistant pneumococci: a renewed threat in respiratory infections. Scand J Infect Dis Suppl 93: 55-62
33. Goldstein FW, Geslin P, Acar JF, French Study Group (1994) Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistant Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 13: 33-34
34. Hakenbeck R (1995) Epidemiologie penicillinresistenter Pneumokokken. Chemotherapie J 4: 124-128
35. Hakenbeck R, Tarpay M, Tomasz A (1980) Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 17: 364-371
36. Hansman D, Bullen MM (1967) A resistant pneumococcus [letter]. Lancet: 264-265
37. Hansman D, Devitt L, Miles H, Riley I (1974) Pneumococci relatively insensitive to penicillin in Australia and New Guinea. Med J Aust 2: 353-356
38. Hospital Infection Control Practices AC (1995) Recommendations for preventing the spread of vancomycin resistance. MMWR 44
39. Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29 Suppl A: 19-24
40. Jevons MP (1961) Celebin-resistant staphylococci. BMJ 1: 124-125
41. Jones RN, Barry AL, Gardiner RV, Packer RR (1989) The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers. Diagn Microbiol Infect Dis 12: 385-394
42. Jones RN, Kehrberg EN, Erwin ME, Anderson SC (1994) Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group. Diagn Microbiol Infect Dis 19: 203-215
43. Karanfil LV, Murphy M, Josephson A, Gaynes R, Mandel L, Hill BC, Swenson JM (1992) A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit Infect Control Hosp Epidemiol 13: 195-200
44. Karchmer AW, Archer GL, Dismukes WE (1983) Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 98: 447-455
45. Kayser FH (1996) Basic aspects of antibiotic resistance in the multiresistant Staphylococcus: An overview. Chemotherapy 42 (Suppl 2): 2-12
46. Klugman K (1990) Pneumococcal resistance to antibiotics. Clin Microbiol Rev 3: 171-196
47. Konno M (1995) Nosocomial infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Infect Chemother 1: 30-39
48. Kotilainen P, Huovinen S, Jarvinen H, Aro H, Huovinen P (1995) Epidemiology of the colonization of inpatients and outpatients with ciprofloxacin-resistant coagulase-negative staphylococci. Clin Infect Dis 21: 685-687
49. Kresken M, Hafner D (1996) Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa Chemotherapie Journal 4: 225-230
50. Krogstad DJ, Pargwette AR (1980) Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall. Antimicrob Agents Chemother 17: 965-968
51. Layton MC, Patterson JE (1994) Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital. Antimicrob Agents Chemother 38: 1664-1667
52. Livornese LL, Jr., Dias S, Samel C, Romanowski B, Taylor S, May P, Pitsakis P, Woods G, Kaye D, Levison ME, et al. (1992) Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 117: 112-116
53. Lyytikainen O, Vaara M, Jarviluoma E, Rosenqvist K, Tiittanen L, Valtonen V (1996) Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period. Eur J Clin Microbiol Infect Dis 35: 133-138
54. Marton A (1992) Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis 15: 106-111
55. Maugein J, Pellegrin JL, Brossard G, Fourche J, Leng B, Reiffers J (1990) In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients. Antimicrob Agents Chemother 34: 901-903
56. Moreno F, Crisp C, Jorgensen JH, Patterson JE (1995) Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 21: 1308-1312
57. Muñoz R, Musser JM, Crain M, Briles DE, Marton A, Parkinson AJ, Sorensen U, Tomasz A (1992) Geographic distribution of penicillin-resistant clones of Streptococcus penumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis 35: 112-118
58. Murray BE (1990) The life and times of the Enterococcus. Clin Microbiol Rev 3: 46-65
59. Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Stratford RE, Cooper RD (1995) Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrob Agents Chemother 39: 2585-2587
60. Noble WC (1996) Resistance to glycopeptide antibiotics in Staphylococcus aureus: An emerging problem? Chemotherapy 42 (Suppl 2): 27-29
61. Noble WC, Virani Z, Cree RG (1992) Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 72: 195-198
62. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Toison JS, Martone WJ (1992) Methicillin-resistant Staphylococcus aureus in U.S. hospitals. 1975-1991. Infect Control Hosp Epidemiol 13: 582-586
63. París MM, Ramilo O, McCracken GH, Jr (1995) Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 39: 2171-2175
64. Perichon B, Reynolds PE, Courvalin P (1996) A vanD-type glycopeptide-resistant Enterococcus faecium. ICAAC New Orelans LB12
65. Peters G (ed) (1996) Die Rolle von Clindamycin in der Therapie von Staphylokokkenerkrankungen. Sociomedico Verlag, Gräfelfing
66. Peters G, Becker K (1997) Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus. Drugs 52 (Suppl 2): 50-54
67. Peters G, von Eiff C, Herrmann M (1995) The changing pattern of coagulase-negative staphylococci as infectious pathogenes. Curr Opin Infect Dis 8 (Suppl 1): 12-19
68. Piddock LJ (1994) New quinolones and gram-positive bacteria. Antimicrob Agents Chemother 38: 163-169
69. Reinert RR, Lütticken R, Kaufhold A (1993) Aktuelle Daten zur Antibioti-kaempfindlichkeit von Streptococcus pneumoniae (Pneumokokken). Die Bedeutuns von penicillinresistenten Isolaten. Med Klin 88: 357-361
70. Reinert RR, Queck A, Kaufhold A, Kresken M, Lütticken R (1994) Antibiotic sensitivity of Streptococcus pneumoniae isolated from normally sterile body sites: first results of a multicenter study in Germany [letter]. Infection 22: 113-114
71. Rouch DA, Messerotti LJ, Loo LS, Jackson CA, Skurray RA (1989) Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257. Mol Microbiol 3: 161-175
72. Sánchez C, Armengol R, Lite J, Mir I, Garau J (1992) Penicillin-resistant pneumococci and community-acquired pneumonia [letter]. Lancet 339: 988
73. Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91: 72S-75S
74. Schwalbe RS, Stapleton JT, Gilligan PH (1987) Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 316: 927-931
75. Spencer RC (1996) Predominant pathogens found in the european prevalence of infection in intensive care study. Eur J Clin Microbiol Infect Dis 15: 281-285
76. Swartz MN (1994) Hospital acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci 91: 2420-2427
77. Thomas WD Jr, Archer GL (1989) Mobility of gentamicin resistance genes from staphylococci isolated in the United States: identification of Tn4031. a gentamicin resistance transposon from Staphylococcus epidermidis. Antimicrob Agents Chemother 33: 1335-1341
78. Thornsberry C, Hill BC, Swenson JM, McDougal LK (1983) Rifampin: spectrum of antibacterial activity. Rev Infect Dis 5 (Suppl 3): S412-417
79. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW (1996) Risk factors associated with Vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 23: 767-772
80. Urban C, Mariano N, Mosinka Snipas K, Wadee C, Chahrour T, Rahal JJ (1996) Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin. J Antimicrob Chemother 37: 361-364
81. Utrup LJ, Finlay JE, Rittenhouse SF, Poupard JA (1994) Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolates. Diagn Microbiol Infect Dis 20: 171-174
82. Veach LA, Pfaller MA, Barrett M, Koontz FP, Wenzel RP (1990) Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol 28: 2064-2068
83. von Eiff C, Peters G (1997) In-vitro activity of RP 59500, a new semisynthetic injectable pristinamycin against staphylococci. Zbl Bakt 283: 497-501
84. Voss A, Kresken M (1996) Antibiotic resistance in staphylococci in Europe. Chemotherapy 42 (Suppl 2): 13-18
85. Voss A, Machka K, Lenz W, Milatovic D (1992) Vorkommen. Häufigkeit und Resistenzverhalten von Methicillin-Oxacillin-resistenten Staphylococcus-aureus-Stämmen in Deutschland. Dtsch Med Wochenschr 117: 1907-1912
86. Voss A, Milatovic D, Wallrauch Schwarz C, Rosdahl VT, Braveny I (1994) Methicillinresistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13: 50-55
87. Weisblum B (1985) Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression - a review. J Antimicrob Chemother 16 (Suppl A): 63-90
88. Williamson R, LeBouguenec C, Gutmann L, Horaud T (1985) One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. J Gen Microbil 131: 1933-1940
89. Witte W, Heuck D, Klare I, Kniehl E (1996) Stellungnahme zu "Recommendations for preventing the spread of vancomycin resistance". Mikrobiologe 6: 134-136
90. Wolfson JS, Hooper DC (1985) The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 28: 581-586
91. Woodford N, Johnson AP, Morrison D (1995) Current perspectives on glycopeptide resistance. Clin Microbiol Rev 8:585-615